Holdings
EcoR1 Capital, LLC
As of Sep 30, 2026, EcoR1 Capital, LLC reported 32 positions worth US$1.95B. Largest: Zymeworks Inc., AnaptysBio, Inc. and CG Oncology, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Zymeworks Inc. | 23M | US$608M | no change | Sep 30, 2026 |
| AnaptysBio, Inc. | 7.88M | US$396M | no change | Sep 30, 2026 |
| CG Oncology, Inc. | 1.87M | US$133M | +378K | Sep 30, 2026 |
| Eton Pharmaceuticals, Inc. | 2.47M | US$127M | +299K | Sep 30, 2026 |
| First Tracks Biotherapeutics, Inc. | 3.17M | US$113M | no change | Sep 30, 2026 |
| Aktis Oncology, Inc. | 4.82M | US$93.9M | no change | Sep 30, 2026 |
| Alto Neuroscience, Inc. | 2.23M | US$57M | new | Sep 30, 2026 |
| Lakefront Biotherapeutics | 1.67M | US$49.4M | no change | Sep 30, 2026 |
| Erasca, Inc. | 2.95M | US$43.2M | +2.62M | Sep 30, 2026 |
| ORIC Pharmaceuticals, Inc. | 3.03M | US$40.8M | −3.7M | Sep 30, 2026 |